Status:
UNKNOWN
Efficacy, Safety and Re-occurrence of Pneumothorax and Hydro-pneumothorax With Talc and Pyodine Pleurodesis
Lead Sponsor:
Dow University of Health Sciences
Conditions:
Secondary Pneumothorax
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
PHASE2
Brief Summary
Abstract: INTRODUCTION: Pneumothorax and hydro-pneumothorax are the most common thoracic injuries and poses a risk of serious morbidity.To prevent the lung from collapsing in such condition, pleurod...
Detailed Description
Introduction: Pneumothorax and hydro-pneumothorax are the common thoracic injuries which have a severe risk of morbidity. In such a condition either gas or air remains in pleural cavity, a space betw...
Eligibility Criteria
Inclusion
- Patients of both sex with aged 18 years to 60 years suffering with Pneumothorax and hydro-pneumothorax with lung expanded in chest x-ray.
- Patients of Hydro-pneumothorax with fluid less than 50 ml /24 hour
- Patients having chest tube placed and their column is moving
Exclusion
- Patients with broncho-pulmonary fistula will not be a pleurodesis
- Patients with malignant pleural effusion
- Patients with thoraco-scopic procedure having done pleurodesis
Key Trial Info
Start Date :
October 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04130451
Start Date
October 25 2019
End Date
December 1 2019
Last Update
October 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mateen Ahmed Khan
Karachi, Pakistan, 78200